What is the EU's AI plan?

World leaders, particularly within the EU, are navigating the complex landscape of AI development by weighing potential gains against associated risks. The recent Artificial Intelligence Action Summit in Paris underscored the EU's efforts to bolster AI investments, but highlighted the challenges it faces in remaining competitive compared to major players like the US and China. Conversations at the summit underscore the importance of public-private partnerships and the EU's regulatory framework in shaping the AI landscape, particularly in sectors like pharmaceuticals, where significant advancements are being made.

There's a fair bit of AI development happening at the sectoral level in pharmaceutical development, for example, there's a lot happening in medicine. So there's a lot happening. It might not be as newsworthy as something like Mistral or it might not be a unicorn worth multiple billions of dollars or euros, I should say. But there's a lot happening in Europe, from an AI perspective.

I need to reach, pick up the phone and speak to the vendor, because there's not a piece of software that can scan my SaaS solution and tell me that, 'Oh, this SaaS solution you're using, the CRM and the cloud that you're using, it has 26 AI-enabled features, of which six are high risk. So you better pay attention to those and get a bit more detail'. Nothing's going to do that for you. You have to pick up the phone and speak to the vendor.

And Ursula [von der Leyen] said - it was very nuanced yesterday - she made a comment, a throwaway comment in her speech, that you have 27 countries with one piece of legislation, one set of rules. And the fact of the matter is, for any business and for any outsider looking in, the US is going

Read at ITPro